Safe Brain Initiative, Operationalizing Precision Anaesthesia
Launched by UNIVERSITY OF SOUTHERN DENMARK · Feb 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Safe Brain Initiative is a clinical trial focused on improving the experiences of patients undergoing surgery, particularly those who may suffer from neurocognitive disorders or related issues after their operations. The trial aims to reduce common side effects like nausea, pain, anxiety, and confusion, which can affect patients' recovery and overall quality of life. By collecting and analyzing real-world data from various hospitals, the initiative seeks to create better guidelines for doctors and nurses to follow, helping them tailor care to each patient's needs and ultimately enhancing patient safety and satisfaction.
To participate in this trial, individuals must be at least 18 years old. The study is currently recruiting patients, regardless of gender. Participants can expect to be involved in a system that gathers important information about their health and experiences before, during, and after surgery. This data will help healthcare providers understand the causes of different side effects and improve care practices over time. The Safe Brain Initiative is designed to make surgeries safer and recovery smoother for everyone involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • All patients from age ≥18
- Exclusion Criteria:
- • • All patients from age \<18
About University Of Southern Denmark
The University of Southern Denmark (SDU) is a prominent research institution dedicated to advancing knowledge and innovation across various fields, including health sciences. As a clinical trial sponsor, SDU is committed to conducting rigorous and ethically sound research aimed at improving patient outcomes and informing clinical practices. Leveraging its multidisciplinary expertise and state-of-the-art facilities, SDU collaborates with healthcare professionals, industry partners, and regulatory bodies to develop and execute clinical trials that adhere to the highest standards of scientific integrity and compliance. Through its research initiatives, SDU seeks to contribute to the global body of medical knowledge and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nykøbing Falster, , Denmark
Patients applied
Trial Officials
Finn M. Radtke, Professor
Principal Investigator
University of Southern Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials